Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,878
Total Claims
$319K
Drug Cost
411
Beneficiaries
$775
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-95%
Opioid rate vs peers
0.1% vs 2.5% avg
-31%
Cost per patient vs peers
$775 vs $1,128 avg
-20%
Brand preference vs peers
6.7% vs 8.4% avg
Opioid Prescribing
0.1%
Opioid Rate
15
Opioid Claims
$76
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 855 claims · $188K
Generic: 11,881 claims · $128K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 65 | $38K |
| Insulin Nph Hum/Reg Insulin Hm | 128 | $27K |
| Rivaroxaban | 35 | $19K |
| Mesalamine | 12 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 32 | $12K |
| Losartan Potassium | 698 | $8,701 |
| Levothyroxine Sodium | 599 | $8,498 |
| Insulin Regular, Human | 45 | $7,976 |
| Insulin Nph Human Isophane | 40 | $6,771 |
| Rivastigmine | 27 | $4,220 |
| Atorvastatin Calcium | 572 | $4,217 |
| Bimatoprost | 12 | $4,178 |
| Midodrine Hcl | 12 | $3,759 |
| Levothyroxine Sodium | 49 | $3,520 |
| Insulin Glargine-Yfgn | 25 | $3,315 |
Prescribing Profile
Patient Profile
75
Avg Age
56%
Female
2.14
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data